Synonyms: compound 6 [US11091464B2] | EDG-5506 | EDG5506
Compound class:
Synthetic organic
Comment: Sevasemten (EDG-5506) is an oral small molecule that inhibits fast skeletal muscle myosin ATPase [1], with the intention of behaviour as a muscle stabiliser for the treatment of dystrophinopathies.
|
|
References |
1. Hunt K, Koch K, Russell A, Schlachter S, Winship P, Steele C. (2021)
Pyridazinone compounds and uses thereof. Patent number: US11091464B2. Assignee: Edgewise Therapeutics Inc. Priority date: 03/11/2020. Publication date: 17/08/2021. |
2. Russell AJ, DuVall M, Barthel B, Qian Y, Peter AK, Newell-Stamper BL, Hunt K, Lehman S, Madden M, Schlachter S et al.. (2023)
Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy. J Clin Invest, 133 (10). [PMID:36995778] |